Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-06-2023 | Anti-NMDA Receptor Encephalitis | Case report

Immune-globulin/methylprednisolone/rituximab

Lack of efficacy: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Zhang H, et al. Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study. Frontiers in Neurology 13: 12 Apr 2022. Available from: URL: http://www.frontiersin.org/Neurology Zhang H, et al. Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study. Frontiers in Neurology 13: 12 Apr 2022. Available from: URL: http://​www.​frontiersin.​org/​Neurology
Metadata
Title
Immune-globulin/methylprednisolone/rituximab
Lack of efficacy: 2 case reports
Publication date
01-06-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41887-8

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs